We are pleased to inform you we have just published the Acta Biomedica 1/2023
Click on the link to see the Table of Contents
Read more
Acta Biomedica (ActaBiomed) is an international peer-reviewed, open access bi-monthly Journal devoted to disseminate new knowledges on a broad spectrum of medical disciplines and sub-specialities. Topics of Journal interest include, but are not limited to: Aging/Geriatrics, Allergy/Asthma, Arthritis/Rheumatic Disease, Cancer, Coronavirus (COVID-19), Diabetes, Humanities, Oncol
Read More
Page e2023064
Page e2023046
Page e2023081
Page e2023003
Page e2023056
We are pleased to inform you we have just published the Acta Biomedica 1/2023
Click on the link to see the Table of Contents
Starting from 13th February 2023, an article processing charge (APC) of 500,00 € (VAT included) will be due for the accepted papers. For Letters to the Editor a publication charge of 200,00 € (VAT included) is requested. The publication fees are requested to cover the cost of editorial work, editing, publishing online and in print.
...
See at: https://www.mattioli1885journals.com/index.php/actabiomedica/publicationfee
Vol. 94 No. 1 (2023)
Published: 13-02-2023
Page e2023034
Page e2023011
Page e2023021
Page e2023025
Page e2023028
Page e2023026
Page e2023009
Page e2023006
Page e2023013
Page e2023045
Page e2023036
Page e2023032
Page e2023031
Page e2023007
Page e2023030
Page e2023061
Page e2023063
Page e2023005
Page e2023010
Page e2023019
Page e2023038
Page e2023018
Page e2023039
Page e2023020
Page e2023008
Page e2023035
THANK YOU to our editorial team, reviewers and authors
Acta Biomedica (ABM) first and foremost would like to thank all Reviewers who have generously devoted their time and competences to ensure the quality of the research published in each issue of ABM. Thank you to all Authors for their kind co-operation extended during the various stages of processing of the manuscript, the Associate Editors and Editorial Board for their advice and guidance with regard to the manuscripts submitted for publication.
Acta Biomedica is glad of progress that has taken place in 2022 and look forward to the support of Authors, peer Reviewers, and Readers in addressing the challenges of the New Year.
Finally, I would like to thanks the Readers of Acta Biomedica for their interest in the journal and encourage all of them to send us their invaluable feedback and ideas for further improvement of our journal.
Sincerely yours.
Maurizio Vanelli
Editor in Chief of Acta Biomedica
Acta Bio Medica is indexed by: Index Medicus/Medline, PubMedCentral, Excerpta Medica (EMBASE), the Elsevier BioBASE, Scopus.